U.S. private hiring rebounded in September after a weak August, with education and health services leading the gains even as financial and professional services lost jobs.

Integer said the HSR waiting period ended early for KKR’s $5.7 billion acquisition, removing one closing condition ahead of an Oct. 21 shareholder vote.

August spending rose $190.8 billion and increased 0.6% after inflation, while BEA’s annual update revised recent PCE inflation and spending history.

ONS data raised April-to-June growth from 0.4% to 0.5%, with revised business survey data in professional, scientific and technical activities driving the upgrade.

Only customary closing conditions remain after the regulatory review, while Qorvo shareholders are set to receive $32.50 in cash plus 0.960 Skyworks share for each Qorvo share.

Japan’s latest Ministry of Finance disclosures showed no foreign-exchange intervention in the month through Sept. 28, while a same-day 2-year government bond auction cleared at higher yields on solid demand.

Sagimet is selling common stock and pre-funded warrants at prices equivalent to $10 per share, with proceeds earmarked for denifanstat, TVB-3567 and its topical FASN inhibitor program.

The September minutes show Anna Seim and Governor Erik Thedéen leaning toward a November increase, while the board kept room to respond to inflation, growth and the krona.

Pitney Bowes lowered the margin on its Term Loan B by 75 basis points to SOFR plus 300 basis points, with the March 2032 maturity and other terms unchanged.

At Week 16, 53% of EBGLYSS patients had clear or almost clear hands and feet versus 27% on placebo, and Lilly has submitted the data to the FDA for a potential label update.